What youll learn: Insurance coverage for semaglutide depends on your plan, your diagnosis, and even your state
Eli Lilly's high valuation metrics, with a P/E of 42.47 and P/FCF of 102.62 , leave little room for error if growth decelerates or profitability is squeezed more than anticipated
Note from Healthy For Life Meals: If youre trying to maintain muscle while losing weight on a GLP-1, having protein-balanced meals ready to go can make it much easier to stay on track
Across both diabetic and nondiabetic cohorts, GLP-1s were associated with a meaningfully lower fracture risk
Phase III results for retatrutide are set to be released later in 2025 and in early 2026, but an earlier phase II trial recorded between a 7.2% and 17.5% reduction in body weight after 24 weeks, depending on the dose (7.2% on 1mg, 17.5% on 12mg), and up to a 24.2% reduction in body weight after 48 weeks for those on 12mg (-8.7% change for those on 1mg) 8